These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 14586903)

  • 1. Prophylactic and preemptive therapies for hepatitis C virus-infected patients undergoing liver transplantation.
    Terrault NA
    Liver Transpl; 2003 Nov; 9(11):S95-S100. PubMed ID: 14586903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early antiviral treatment of hepatitis C virus recurrence after liver transplantation in HIV-infected patients.
    Castells L; Esteban JI; Bilbao I; Vargas V; Allende H; Ribera E; Piron M; Sauleda S; Len O; Pahissa A; Esteban R; Guardia J; Margarit C
    Antivir Ther; 2006; 11(8):1061-70. PubMed ID: 17302376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preemptive therapy with pegylated interferon alpha-2b and ribavirin after liver transplantation for hepatitis C cirrhosis.
    Castedal M; Felldin M; Bäckman L; Olausson M; Friman S
    Transplant Proc; 2005 Oct; 37(8):3313-4. PubMed ID: 16298583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversies in the management of hepatitis C virus infection after liver transplantation.
    Shiffman ML; Vargas HE; Everson GT
    Liver Transpl; 2003 Nov; 9(11):1129-44. PubMed ID: 14586872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of hepatitis C in liver transplant recipients.
    Gordon FD; Kwo P; Vargas HE
    Liver Transpl; 2009 Feb; 15(2):126-35. PubMed ID: 19177439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus.
    Duclos-Vallée JC; Féray C; Sebagh M; Teicher E; Roque-Afonso AM; Roche B; Azoulay D; Adam R; Bismuth H; Castaing D; Vittecoq D; Samuel D;
    Hepatology; 2008 Feb; 47(2):407-17. PubMed ID: 18098295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of recurrent hepatitis C virus infection after liver transplantation].
    Lengyel G; Tulassay Z
    Orv Hetil; 2007 Oct; 148(40):1875-81. PubMed ID: 17905682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study.
    Carrión JA; Navasa M; García-Retortillo M; García-Pagan JC; Crespo G; Bruguera M; Bosch J; Forns X
    Gastroenterology; 2007 May; 132(5):1746-56. PubMed ID: 17484872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New approaches to the treatment of hepatitis C virus infection after liver transplantation using ribavirin.
    Bizollon T; Ducerf C; Trépo C
    J Hepatol; 1995; 23 Suppl 2():22-5. PubMed ID: 8720290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in liver transplant recipients undergoing antiviral treatment for recurrent hepatitis C.
    Saab S; Oh MK; Ibrahim AB; Durazo F; Han S; Yersiz H; Farmer DG; Ghobrial RM; Goldstein LI; Tong MJ; Busuttil RW
    Liver Transpl; 2007 Jul; 13(7):1032-8. PubMed ID: 17600345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon alfa-2a and ribavirin for recurrent hepatitis C after liver transplantation.
    Mukherjee S
    Transplant Proc; 2005 Dec; 37(10):4403-5. PubMed ID: 16387131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of recurrent hepatitis C.
    Gane E
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S28-37. PubMed ID: 12362295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of sustained virological response in liver transplant recipients with recurrent hepatitis C virus following combination pegylated interferon alfa-2b and ribavirin therapy using tissue hepatitis C virus reverse transcriptase polymerase chain reaction testing.
    Neff GW; O'Brien CB; Cirocco R; Montalbano M; de Medina M; Ruiz P; Khaled AS; Bejarano PA; Safdar K; Hill MA; Tzakis AG; Schiff ER
    Liver Transpl; 2004 May; 10(5):595-8. PubMed ID: 15108250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Steroid-free induction and preemptive antiviral therapy for liver transplant recipients with hepatitis C: a preliminary report from a prospective randomized study.
    Kato T; Yoshida H; Sadfar K; Martinez E; Nishida S; Moon J; Madariaga J; Selvaggi G; Levi D; Ruiz P; Schiff E; Tzakis A
    Transplant Proc; 2005 Mar; 37(2):1217-9. PubMed ID: 15848674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.
    Stravitz RT; Shiffman ML; Sanyal AJ; Luketic VA; Sterling RK; Heuman DM; Ashworth A; Mills AS; Contos M; Cotterell AH; Maluf D; Posner MP; Fisher RA
    Liver Transpl; 2004 Jul; 10(7):850-8. PubMed ID: 15237368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How can we identify better those with recurrent hepatitis C who will respond to therapy? What are the optimal treatment regimen and treatment duration?
    Wright TL
    Liver Transpl; 2003 Nov; 9(11):S109-13. PubMed ID: 14586905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applicability, tolerability and efficacy of preemptive antiviral therapy in hepatitis C-infected patients undergoing liver transplantation.
    Shergill AK; Khalili M; Straley S; Bollinger K; Roberts JP; Ascher NA; Terrault NA
    Am J Transplant; 2005 Jan; 5(1):118-24. PubMed ID: 15636619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-emptive treatment of recurrent hepatitis C infection.
    Charlton M
    Liver Transpl; 2002 Oct; 8(10 Suppl 1):S50-4. PubMed ID: 12362299
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and histological efficacy of pegylated interferon and ribavirin therapy of recurrent hepatitis C after liver transplantation.
    Fernández I; Meneu JC; Colina F; García I; Muñoz R; Castellano G; Fuertes A; Abradelo M; Lumbreras C; Moreno E; Solís-Herruzo JA
    Liver Transpl; 2006 Dec; 12(12):1805-12. PubMed ID: 17133585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection.
    Neff GW; delaGarza J; Shire N; Nishida S; O'Brien CB; Safdar K; Madariaga J; Schiff E; Ruiz P
    Transplant Proc; 2004 Dec; 36(10):3065-7. PubMed ID: 15686695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.